neuroprotectives in acute ischemic stroke, hope or hype?

نویسندگان

mohammad torabi-nami department of neuroscience, school of advanced medical sciences and technologies, shiraz university of medical sciences, shiraz, iran

afshin borhani-haghighi

farzaneh vafaee

چکیده

stroke is a significant public health burden which absolutely requires more effective therapies. the approved treatment options for stroke including tissue plasminogen activators, antiplatelet agents and anticoagulants mainly bear antithrombotic effects. meanwhile, evolving investigational approaches such as collateral therapeutics and neuroprotective agents has thus far been attempted with equivocal effects on stroke outcome. the basic structural and ultrastructural changes following acute ischemic stroke should be well-considered when trying to target oxidative stress and cell death pathways using neuroprotective agents. clearly, the positive results of preclinical studies on neuroprotectives and collateral therapeutics in stroke do not necessarily translate to the true clinical benefits of these agents. as such, several large advance-phased trials have already failed to prove so. on the other hand, controversial results in clinical setting should not discourage further research endeavors on the same. besides, the concurrent use of flow augmentation and neuroprotectives may serve further clinical benefits. based on the available evidence, it appears that optimization of preclinical studies and further well-designed prospective clinical trials let neuroprotection possibly find its position in stroke management.  the present paper discusses key preclinical and clinical studies on neuroprotectives towards improved outcome in acute ischemic stroke.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pharmacogenomics: Hope or Hype?

Much has been made of the potential for personalnot altruistic companies. Incyte Inc. alone holds US ised medicine, where a genomic screen of a patient patents on more than 350 genes and has an estimated could determine which drugs will work and be free of 6,500 applications pending with 10 more applied for side effects in an individual. Much of the hope based each week [3]. They hope to make p...

متن کامل

dysphagia in acute ischemic stroke

Introduction: Swallowing dysfunction complicates acute strokes in 25-32% of cases and directly affects patientschr('39') prognosis and recovery. Dysphagia complicates the course of acute strokes through its potential of the development of chest infection, nutritional problems, and dehydration.  Dysphagia is also an independent predictor of respiratory morbidity and mortality in acute stroke. In...

متن کامل

Personalized medicine: hope or hype?

Medicine has always been personalized. For years, physicians have incorporated environmental, behavioural, and genetic factors that affect disease and drug response into patient management decisions. However, until recently, the 'genetic' data took the form of family history and self-reported race/ethnicity. As genome sequencing declines in cost, the availability of specific genomic information...

متن کامل

Community Informatics: Hope or Hype

Community informatics is a promising strategy for taking advantage of information and communication technologies (ICTs) to further goals of community development. It is important, however, that proponents of this approach recognize that it is based on the assumption that technology in itself can lead to positive social development. This "techno-utopianism" is subject to various critiques, which...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of advanced medical sciences and applied technologies

جلد ۱، شماره ۱، صفحات ۸-۰

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023